Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Stress can alter immunological, neurochemical and endocrinological functions, but its role in cancer progression is not well understood. Here, we show that chronic behavioral stress results in higher levels of tissue catecholamines, greater tumor burden and more invasive growth of ovarian carcinoma cells in an orthotopic mouse model. These effects are mediated primarily through activation of the tumor cell cyclic AMP (cAMP)-protein kinase A (PKA) signaling pathway by the beta(2) adrenergic receptor (encoded by ADRB2). Tumors in stressed animals showed markedly increased vascularization and enhanced expression of VEGF, MMP2 and MMP9, and we found that angiogenic processes mediated the effects of stress on tumor growth in vivo. These data identify beta-adrenergic activation of the cAMP-PKA signaling pathway as a major mechanism by which behavioral stress can enhance tumor angiogenesis in vivo and thereby promote malignant cell growth. These data also suggest that blocking ADRB-mediated angiogenesis could have therapeutic implications for the management of ovarian cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Parallel findings in animal and in vitro models support these data [11, 16–22].”
From Living Well: Protocol for a web-based program to improve quality of life in rural and urban ovarian cancer survivors (2024) · cites this paper as [16]
In the citing paper
“The tumor-promoting effect of catecholamines is mainly mediated by the β2 adrenergic receptor (encoded by ADRB2) activating the cAMP-protein kinase A (PKA) signaling pathway, which is the main mechanism to enhance tumor angiogenesis in the body and promote the growth of malignant cells [(34, 35); Figure 2].”
From Chronic Stress Promotes Cancer Development (2020) · cites this paper as [34]
In the citing paper
“Parallel effects have been observed in experimental animal models of cancer, and those analyses again identify a prominent role for SNS activation of β-adrenergic signaling [43], [44].”
From Human Social Genomics (2014) · cites this paper as [43]
Citations
Cites
Protective and Damaging Effects of Stress Mediators
McEwen, B. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801153380307 · Cited by 6,733
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689 · cited 1×
“Pharmacologic and genetic manipulations identify β-adrenergic signaling as a central mediator of stress effects in the model of stress used here, but these findings do not rule out the possibility that other neuroendocrine signaling pathways might modulate tumor cell biology under other circumstances (for example, str…”
BackgroundStress-induced immune dysfunction: implications for health
Glaser, R., & Kiecolt-Glaser, J. K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1571 · Cited by 2,190 · cited 1×
“Previous research emphasized the role of the immune system in mediating stress effects on tumor growth and metastasi”
Stress, depression, the immune system, and cancer
Reiche, E. M. V., Nunes, S. O. V., & Morimoto, H. K. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01597-9 · Cited by 1,364
The influence of bio-behavioural factors on tumour biology: pathways and mechanisms
Antoni, M. H., Lutgendorf, S. K., Cole, S. W., Dhabhar, F. S., Sephton, S. E., McDonald, P. G., Stefanek, M., & Sood, A. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1820 · Cited by 981
Self-citationPassaniti, A., Taylor, R. M., Пили, Р., Guo, Y., Long, P., Haney, J. A., Pauly, R. R., Grant, D. S., & Martin, G. R. (1992) · PubMed · Cited by 806
Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery
Landen, C. N., Chavez-Reyes, A., Bucana, C., Schmandt, R., Deavers, M. T., Lopez-Berestein, G., & Sood, A. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0530 · Cited by 675 · cited 1×
“To facilitate in vivo distribution, we incorporated the siRNA into a neutral liposome, DOP”
MethodSelf-citationBasu, S., Nagy, J. A., Pal, S., Vasile, E., Eckelhoefer, I. A., Susan Bliss, V., Manseau, E. J., Dasgupta, P. S., Dvorak, H. F., & Mukhopadhyay, D. (2001) · Nature Medicine · doi:10.1038/87895 · Cited by 396
Social support, psychological distress, and natural killer cell activity in ovarian cancer
Lutgendorf, S. K., Sood, A. K., Anderson, B., McGinn, S., Maiseri, H., Dao, M., Sorosky, J. I., De Geest, K., Ritchie, J., & Lubaroff, D. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.015 · Cited by 345 · cited 1×
“Previous research emphasized the role of the immune system in mediating stress effects on tumor growth and metastasi”
BackgroundSelf-citationLutgendorf, S. K., Cole, S. W., Costanzo, E. S., Bradley, S., Coffin, J. E., Jabbari, S., Rainwater, K. K., Ritchie, J. M., Yang, M., & Sood, A. K. (2003) · PubMed · Cited by 330
Self-citation
Research works printed but not linked: 1
- Halder, J. et al. Focal adhesion kinase targeting for therapy of ovarian carcinoma using in vivo siRNA delivery in neutral liposomes. Clin. Cancer Res. (in the press).
Cited by
Items 101–200 of 1,000
Lemeshow, S., Sørensen, H. T., Phillips, G., Yang, E. V., Antonsen, S., Riis, A. H., Lesinski, G. B., Jackson, R., & Glaser, R. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0249 · Cited by 207
“Our in vitro data usingmelanoma (13) and other cancer cell lines (11, 30, 31) suggest that b-blockers exert an antitumor effect via direct action on malignant cells.”
BackgroundHermes, G. L., Delgado, B., Tretiakova, M., Cavigelli, S. A., Krausz, T., Conzen, S. D., & McClintock, M. K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910753106 · Cited by 207
“Furthermore, the adrenergic components of the stress response on angiogenesis could further increase tumor growth (34).”
BackgroundTherapeutic Efficacy of a Novel Focal Adhesion Kinase Inhibitor TAE226 in Ovarian Carcinoma
Halder, J., Lin, Y. G., Merritt, W. M., Spannuth, W. A., Nick, A. M., Honda, T., Kamat, A. A., Han, L. Y., Kim, T. J., Lu, C., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2667 · Cited by 205
Self-citationRole of Focal Adhesion Kinase in Regulating YB–1–Mediated Paclitaxel Resistance in Ovarian Cancer
Kang, Y., Hu, W., Ivan, C., Dalton, H. J., Miyake, T., Pecot, C. V., Zand, B., Liu, T., Huang, J., Jennings, N. B., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt210 · Cited by 204
“2 mL of HBSS) into the peritoneal cavity of the female athymic nude mice (aged 8–12 weeks), which were purchased from the National Cancer Institute–Frederick Cancer Research and Development Center as described previously (13,14).”
MethodSelf-citationNerves in Bone: Evolving Concepts in Pain and Anabolism
Brazill, J. M., Beeve, A. T., Craft, C. S., Ivanusic, J. J., & Scheller, E. L. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3822 · Cited by 205
Campbell, J. P., Karolak, M. R., Ma, Y., Perrien, D. S., Masood-Campbell, S. K., Penner, N. L., Munoz, S. A., Zijlstra, A., Yang, X., Sterling, J. A., et al. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001363 · Cited by 199
“A stimulatory effect of chronic stress has been observed as well on the in vivo growth of parental (non-osteotropic) MDA-MB-231 breast cancer cells implanted orthotopically in the mammary fat pads (MFP) [21].”
BackgroundMethodWatkins, J. L., Thaker, P. H., Nick, A. M., Ramondetta, L. M., Kumar, S., Urbauer, D. L., Matsuo, K., Squires, K. C., Coleman, R. L., Lutgendorf, S. K., et al. (2015) · Cancer · doi:10.1002/cncr.29392 · Cited by 196
“Tumors in these stressed animals demonstrated increased vascularization and enhanced expression of vascular endothelial growth factor, MMP-2, and MMP-9, effects that could be reversed by propranolol.(3) This extensive preclinical evidence that adrenergic signaling promotes the growth of ovarian cancer, combined with s…”
BackgroundSelf-citationCohen, L., Cole, S. W., Sood, A. K., Prinsloo, S., Kirschbaum, C., Arevalo, J. M. G., Jennings, N. B., Scott, S., Vence, L., Wei, Q., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042324 · Cited by 197
“Recent research has found that stress and depression may exert biological effects by increasing pro-inflammatory signaling [6] and a separate literature has linked inflammatory gene expression within the tumor microenvironment to increased angiogenesis, invasion, and metastasis [2].”
BackgroundSelf-citationStress Effects on FosB- and Interleukin-8 (IL8)-driven Ovarian Cancer Growth and Metastasis
Shahzad, M. M. K., Arevalo, J. M., Armaiz-Pena, G. N., Lu, C., Stone, R. L., Moreno-Smith, M., Nishimura, M., Lee, J.-W., Jennings, N. B., Bottsford-Miller, J., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.109579 · Cited by 189
Self-citationCircadian Rhythms and Hormonal Homeostasis: Pathophysiological Implications
Gnocchi, D., & Bruscalupi, G. (2017) · Biology · doi:10.3390/biology6010010 · Cited by 176
“Jet lag and sleep desynchronisation were shown to increase cortisol levels in humans [115,116], and increased cortisol was associated with several pathologies such as cardiometabolic diseases, sleep and mood disorders, [117] and tumours [118,119].”
BackgroundLinking Heart Failure to Cancer: Background Evidence and Research Perspectives
Bertero, E., Canepa, M., Maack, C., & Ameri, P. (2018) · Circulation · doi:10.1161/circulationaha.118.033603 · Cited by 178
Catecholamines Regulate Tumor Angiogenesis
Chakroborty, D., Sarkar, C., Basu, B., Dasgupta, P. S., & Basu, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4289 · Cited by 181
“The mechanism of this NE action has been attributed to the increased VPF/VEGF synthesis (8, 9) and over expression of MMP-2 and MMP-9 through the cAMP-protein kinase A (PKA) pathway (8).”
BackgroundLamy, S., Lachambre, M.-P., Lord-Dufour, S., & Béliveau, R. (2010) · Vascular Pharmacology · doi:10.1016/j.vph.2010.08.002 · Cited by 178
Social influences on clinical outcomes of patients with ovarian cancer
Lutgendorf, S. K., De Geest, K., Bender, D., Ahmed, A., Goodheart, M. J., Dahmoush, L., Zimmerman, M. B., Penedo, F. J., Lucci, J. A., Ganjei-Azar, P., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.4411 · Cited by 177
Self-citationThe trouble with circadian clock dysfunction: Multiple deleterious effects on the brain and body
Zelinski, E. L., Deibel, S. H., & McDonald, R. J. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.01.007 · Cited by 175
Depression, cortisol, and suppressed cell-mediated immunity in metastatic breast cancer
Sephton, S. E., Dhabhar, F. S., Keuroghlian, A. S., Giese-Davis, J., McEwen, B. S., Ionan, A. C., & Spiegel, D. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.07.007 · Cited by 170
Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response
Qiao, G., Chen, M., Bucsek, M. J., Repasky, E. A., & Hylander, B. L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00164 · Cited by 168
“Altogether, these results clearly defined a role for adrenergic signaling in tumor growth and this was shown to be mediated by tumor VEGF production and increased angiogenesis (88).”
BackgroundChronotherapy and the molecular clock: Clinical implications in oncology☆
Innominato, P. F., Lévi, F. A., & Bjarnason, G. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.06.002 · Cited by 164
Sivamani, R. K., Pullar, C. E., Manabat-Hidalgo, C. G., Rocke, D. M., Carlsen, R. C., Greenhalgh, D. G., & Isseroff, R. R. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000012 · Cited by 164
“Sustained elevations in the level of plasma epinephrine are implicated in stress-induced immunosuppression that accompanies depression [41], and have been implicated in tumor angiogenesis contributing to tumor growth [42].”
BackgroundPasquier, E., Street, J., Pouchy, C., Carre, M., Gifford, A. J., Murray, J., Norris, M. D., Trahair, T., Andre, N., & Kavallaris, M. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.205 · Cited by 162
“Preclinical studies have also showed that b-blockers were able to significantly inhibit stress-induced tumour growth and/or metastasis in models of ovarian cancer (Thaker et al, 2006), breast cancer (Sloan et al, 2010) and acute lymphoblastic leukaemia (Lamkin et al, 2012).”
BackgroundTang, J., Li, Z., Lu, L., & Cho, C. H. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.08.009 · Cited by 160
“A growing body of investigations have suggested that stress hormones adrenaline and/or noradrenaline exhibit a tumour-promoting function in a variety of tumour types including but not limited to the cancers of pancreas [22], breast [23], ovary [24,25], colorectum [26], oesophagus [27], lung [28,29], prostate [30], nas…”
BackgroundThe many faces of compartmentalized PKA signalosomes
Torres-Quesada, O., Mayrhofer, J. E., & Stefan, E. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.05.012 · Cited by 163
Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma
Lutgendorf, S. K., Lamkin, D. M., Jennings, N. B., Arevalo, J. M. G., Penedo, F., DeGeest, K., Langley, R. R., Lucci, J. A., Cole, S. W., Lubaroff, D. M., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0230 · Cited by 158
Self-citationThe neuronal influence on tumor progression
Mancino, M., Ametller, E., Gascón, P., & Almendro, V. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.04.005 · Cited by 162
“Stress-related situations can induce the release of neurotransmitters and/or hormones that will further influence tumor onset, development and progression [24,147].”
BackgroundInfluentialUnger, J. M., Moseley, A. B., Cheung, C. K., Osarogiagbon, R. U., Symington, B. E., Ramsey, S. D., & Hershman, D. L. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.02602 · Cited by 173
“Other research has suggested the potential effects of chronic stress exposure on health outcomes through mechanisms of altered immunological and neuroendocrine function, mechanisms which would endure despite access to guideline-based care.(33,34) Additionally, living in a lower socioeconomic area is associated with mo…”
BackgroundNilsson, M. B., Armaiz-Peña, G. N., Takahashi, R., Lin, Y. G., Trevino, J. G., Li, Y., Jennings, N., Arevalo, J. M. G., Lutgendorf, S. K., Gallick, G. E., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611539200 · Cited by 181
Self-citationQin, J., Jin, F., Li, N., Guan, H., Lan, L., Ni, H., & Wang, Y. (2015) · BMB Reports · doi:10.5483/bmbrep.2015.48.5.008 · Cited by 177
“While the mice in chronic stress group were implemented with social isolation stress referred to Anil K Sood (23), and in this group”
BackgroundMethodEng, J. W.-L., Reed, C. B., Kokolus, K. M., Pitoniak, R., Utley, A., Bucsek, M. J., Ma, W. W., Repasky, E. A., & Hylander, B. L. (2015) · Nature Communications · doi:10.1038/ncomms7426 · Cited by 157
Social regulation of leukocyte homeostasis: the role of glucocorticoid sensitivity
Cole, S. W. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.02.006 · Cited by 156
“…al., 2006; Kroenke et al., 2006) and in animal models (Sklar and Anisman, 1980; Ben-Nathan et al., 1989; Shively et al., 1989; Clausing et al., 1994; Hilakivi-Clarke and Dickson, 1995; Villano Bonamin et al., 2001; Wu et al., 2001; McClintock et al., 2005; Hermes et al., 2006; Thaker et al., 2006).”
Self-citationMadden, K. S., Szpunar, M. J., & Brown, E. B. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1348-y · Cited by 152
“showed that chronic stress exposure increased VEGF production in vivo in MB-231 tumors through a b-AR-mediated mechanism [1], but a direct effect of tumor cell b-AR stimulation in vivo was not tested with MB-231, leaving open the possible involvement of VEGF-expressing stromal cells (such as macrophages) in the stress…”
An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic
Fernández, A., Sanguino, A., Peng, Z., Ozturk, E., Chen, J., Crespo, A., Wulf, S., Shavrin, A., Qin, C., Ma, J., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32373 · Cited by 158
Self-citationLi, J., Yang, X., Wang, Y., Feng, M., Liu, X., Zhang, Y., Huang, S., Wu, Z., Xue, F., Qin, W., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.02.025 · Cited by 160
“Previous studies have demonstrated noticeable effects of NE/E on cancer cell invasion and anoikis [6,7], but the role of the adrenergic system in HCC cell behavior has not been reported.”
BackgroundGross, A. L., Gallo, J. J., & Eaton, W. W. (2010) · Cancer Causes & Control · doi:10.1007/s10552-009-9449-1 · Cited by 152
Cancer and stress: NextGen strategies
Cui, B., Peng, F., Lu, J., He, B., Su, Q., Luo, H., Deng, Z., Jiang, T., Su, K., Huang, Y., et al. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.11.005 · Cited by 152
Why do patients with cancer die?
Boire, A. A., Burke, K., Cox, T. R., Guise, T. A., Jamal‐Hanjani, M., Janowitz, T., Kaplan, R. N., Lee, R. J., Swanton, C., Heiden, M. G. V., et al. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00708-4 · Cited by 175
“Although the burgeoning field of cancer neuro-science provides evidence that the efferent system can support local and metastatic tumour growth 97–99 , at this time, it is unclear whether the reverse is also true.”
Impact of beta blockers on epithelial ovarian cancer survival
Diaz, E. S., Karlan, B. Y., & Li, A. J. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.07.102 · Cited by 155
“norepinephrine promote ovarian cancer cell growth in vivo [8–10].”
BackgroundInfluentialJi, Y., Chen, S., Xu, C., Li, L., & Xiang, B. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13388 · Cited by 160
Beyond the gut: decoding the gut–immune–brain axis in health and disease
Park, J. C., Chang, L., Kwon, H.-K., & Im, S.-H. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01333-3 · Cited by 149
Nilsson, M. B., Sun, H., Diao, L., Tong, P., Liu, D., Li, L., Fan, Y., Poteete, A., Lim, S.-O., Howells, K., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aao4307 · Cited by 146
Self-citationThe Neuroendocrine Impact of Chronic Stress on Cancer
Thaker, P. H., Lutgendorf, S. K., & Sood, A. K. (2007) · Cell Cycle · doi:10.4161/cc.6.4.3829 · Cited by 164
“Betablockers have shown to block the deleterious effects of stress in both in vitro and in vivo models of several carcinomas [17,21,46].”
BackgroundInfluentialSelf-citationPaternal Psychological Stress Reprograms Hepatic Gluconeogenesis in Offspring
Wu, L., Lü, Y., Jiao, Y., Liu, B., Li, S., Li, Y., Xing, F., Chen, D., Liu, X., Zhao, J., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.01.014 · Cited by 150
Self-citationMolecular Mechanisms of Cancer-Induced Sleep Disruption
Walker, W. H., II, & Borniger, J. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112780 · Cited by 162
Neuroendocrine influences on cancer progression
Armaiz-Pena, G. N., Cole, S. W., Lutgendorf, S. K., & Sood, A. K. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.06.005 · Cited by 145
Self-citationNuclear factor κB transcription factors are coexpressed and convey a poor outcome in ovarian cancer
Annunziata, C. M., Stavnes, H. T., Kleinberg, L., Berner, A., Hernandez, L. F., Birrer, M. J., Steinberg, S. M., Davidson, B., & Kohn, E. C. (2010) · Cancer · doi:10.1002/cncr.25190 · Cited by 145
“Elevated MMP9 expression has been linked to enhanced angiogenesis and metastasis in several studies of ovarian cancer cell line models.(10,11,25,26)”
BackgroundWood, C. A., Han, S., Kim, C. S., Wen, Y., Sampaio, D. R. T., Harris, J. T., Homan, K. A., Swain, J. L., Emelianov, S., Sood, A. K., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25452-3 · Cited by 151
Self-citationNeuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer
Landen, C. N., Lin, Y. G., Armaiz Pena, G. N., Das, P. D., Arevalo, J. M., Kamat, A. A., Han, L. Y., Jennings, N. B., Spannuth, W. A., Thaker, P. H., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0858 · Cited by 144
“Catecholamines have been shown to increase tumor growth and angiogenesis via h-adrenergic receptors (hAR) on malignant ovarian cancer cells (1, 8).”
BackgroundSelf-citationSustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction
Allen, J. K., Armaiz-Peña, G. N., Nagaraja, A. S., Sadaoui, N. C., Ortíz, T., Dood, R. L., Ozcan, M., Herder, D. M., Haemmerle, M., Gharpure, K. M., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-16-1701 · Cited by 145
“We induced stress experimentally by using a restraintstress procedure that has been previously described (7).”
Self-citationRole of the nervous system in cancer metastasis
Kuol, N., Stojanovska, L., Apostolopoulos, V., & Nurgali, K. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0674-x · Cited by 141
“In the xenograft models of ovarian cancer, chronic stress mediates the vascularization of intraperitoneal metastasis and enhances tumor angiogenesis via increasing VEGF expression [48, 49].”
BackgroundNeuroendocrine modulation of cancer progression
Armaiz-Peña, G. N., Lutgendorf, S. K., Cole, S. W., & Sood, A. K. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2008.06.007 · Cited by 161
“The effect of norepinephrine with regard to VEGF stimulation was abolished by a beta-blocker, and mimicked by agonists and thought to be mediated via β-adrenergic receptors (Thaker et al., 2006).”
Self-citationEssential Neuroscience in Immunology
Chavan, S. S., & Tracey, K. J. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601613 · Cited by 139
Williams, J. B., Pang, D., Delgado, B., Kocherginsky, M., Tretiakova, M., Krausz, T., Pan, D., He, J., McClintock, M. K., & Conzen, S. D. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0238 · Cited by 137
“, the β-adrenergic receptors 1 and 2 and glucocorticoid receptor (GR)] are expressed in breast (4, 5), ovarian (6), and prostate (7) cancer epithelium, as well as in diverse cell types of the surrounding stroma, provides evidence of potential physiologic connections between the (a) social environment, (b) neuroendocri…”
BackgroundGanz, P. A., Habel, L. A., Weltzien, E. K., Caan, B. J., & Cole, S. W. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1505-3 · Cited by 137
“Those effects are mediated predominately by inhibition of beta-2 adrenergic receptor signaling in tumor cells, vascular endothelial cells, and monocyte/ macrophages, resulting in reduced signal transduction to support the expression of pro-metastatic and pro-angiogenic genes [29, 30].”
BackgroundSelf-citationChronic stress enhances progression of acute lymphoblastic leukemia via β-adrenergic signaling
Lamkin, D. M., Sloan, E. K., Patel, A. J., Chiang, B. S., Pimentel, M. A., Ma, J. C. Y., Arevalo, J. M. G., Morizono, K., & Cole, S. W. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.01.013 · Cited by 148
Self-citationPark, S. Y., Kang, J. H., Jeong, K. J., Lee, J., Han, J. W., Choi, W. S., Kim, Y. K., Kang, J., Park, C. G., & Lee, H. Y. (2011) · International Journal of Cancer · doi:10.1002/ijc.25589 · Cited by 135
“Recently, Thaker et al.(1) demonstrated that chronic stress caused increased tumor burdens and vascularization in orthotopic models of ovarian cancer.”
BackgroundResultInfluentialRetractedSignaling pathways in the development of infantile hemangioma
Ji, Y., Chen, S., Li, K., Li, L., Xu, C., & Xiang, B. (2014) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-7-13 · Cited by 145
“of EPAC leads to the Rap1A-mediated activation of Raf/MAPK signaling pathw demonstrated that β-adrenergic signaling can regulate multiple fundamental biological processes underlying the progression and metastasis of tumors, including the promotion of inflammation [72-74], angiogenesis [75-78], migration [79], invasion…”
BackgroundFOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair
Park, Y.-Y., Jung, S. Y., Jennings, N. B., Rodriguez-Aguayo, C., Peng, G., Lee, S.-R., Kim, S. B., Kim, K., Leem, S.-H., Lin, S.-Y., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs167 · Cited by 135
“Female athymic nude mice (NCr-nu) were purchased from the NCI-Frederick Cancer Research and Development Center (Frederick, MD) and maintained as described previously (21).”
Self-citationArchie, P., Bruera, E. D., & Cohen, L. G. (2013) · Supportive Care in Cancer · doi:10.1007/s00520-013-1841-4 · Cited by 170
Partecke, L. I., Speerforck, S., Käding, A., Seubert, F., Kühn, S., Lorenz, E., Schwandke, S., Sendler, M., Keßler, W., Trung, D. N., et al. (2016) · Pancreatology · doi:10.1016/j.pan.2016.03.005 · Cited by 146
“Thereby, chronic stress could further worsen the prognosis of malignancies in general and pancreatic cancer in particular leaving the beta-adrenergic system as a possible target for therapies [6,8].”
BackgroundInfluentialShao, S., Jia, R., Zhao, L., Zhang, Y., Guan, Y., Wen, H., Liu, J., Zhao, Y., Feng, Y., Zhang, Z., et al. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153606 · Cited by 144
Propranolol Reduces Cancer Risk
Chang, P., Huang, W., Lin, C., Huang, T., Wu, Y., Chen, J.-H., & Kao, C. (2015) · Medicine · doi:10.1097/md.0000000000001097 · Cited by 134
“The effects of stress are mediated mainly through activation of the cancer cell b2-AR and its downstream cell cyclic AMP-protein kinase A signaling pathway.(1,4) These studies have clarified the relationships between stress and cancer progression.”
BackgroundBiobehavioral Influences on Cancer Progression
Costanzo, E. S., Sood, A. K., & Lutgendorf, S. K. (2011) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2010.09.001 · Cited by 126
“These effects were mediated by increases in VEGF and angiogenesis induced by beta-adrenergic pathways, could be replicated by the betaadrenergic agonist isoproterenol, and were blocked by propranolol [91].”
BackgroundSelf-citationZhao, J., Wang, H., Hsiao, C.-H., Chow, D. S., Koay, E. J., Kang, Y., Wen, X., Huang, Q., Ma, Y., Bankson, J. A., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.014 · Cited by 132
“MRI images were acquired on a Biospec USR70/30 imaging system (Bruker Biospin MRI, Billerica, MA) equipped with a 7T magnet using micro-imaging gradient and a purpose-built small animal coil [18].”
Self-citationNerve-cancer interactions in the stromal biology of pancreatic cancer
Demir, İ. E., Friess, H., & Ceyhan, G. O. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00097 · Cited by 139
“Interestingly, PSCs can also secrete high levels of matrix-metalloproteinase-2, even much higher than the level produced by PCa cells, thereby potentially enhancing their in-tissue invasiveness (Schneiderhan et al., 2007).”
BackgroundYap, A., Lopez-Olivo, M. A., Dubowitz, J., Pratt, G., Hiller, J., Gottumukkala, V., Sloan, E., Riedel, B., & Schier, R. (2018) · British Journal of Anaesthesia · doi:10.1016/j.bja.2018.03.024 · Cited by 124
PGE2 promotes angiogenesis through EP4 and PKA Cγ pathway
Zhang, Y., & Daaka, Y. (2011) · Blood · doi:10.1182/blood-2011-04-350587 · Cited by 125
Depression as a Risk Factor for Cancer: From Pathophysiological Advances to Treatment Implications
Currier, M. B., & Nemeroff, C. B. (2014) · Annual Review of Medicine · doi:10.1146/annurev-med-061212-171507 · Cited by 126
Nerves in the Tumor Microenvironment: Origin and Effects
Wang, W., Li, L., Chen, N., Niu, C. S., Li, Z., Hu, J., & Cui, J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.601738 · Cited by 151
β-Adrenergic Signaling Impairs Antitumor CD8+ T-cell Responses to B-cell Lymphoma Immunotherapy
Nissen, M. D., Sloan, E. K., & Mattarollo, S. R. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0401 · Cited by 124
The neural addiction of cancer
Magnon, C., & Hondermarck, H. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00556-8 · Cited by 137
Vitlic, A., Lord, J. M., & Phillips, A. C. (2014) · AGE · doi:10.1007/s11357-014-9631-6 · Cited by 123
Li, Y., Pham, V., Bui, M., Song, L., Wu, C., Walia, A. S., Uchio, E., Smith-Liu, F., & Zi, X. (2017) · Current Pharmacology Reports · doi:10.1007/s40495-017-0106-1 · Cited by 139
Self-citationCancer metastasis: Molecular mechanisms and clinical perspectives
Khan, S. U., Fatima, K., Malik, F. A., Kalkavan, H., & Wani, A. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108522 · Cited by 132
Dhabhar, F. S., Saul, A. N., Holmes, T. H., Daugherty, C., Neri, E., Tillie, J. M., Kusewitt, D., & Oberyszyn, T. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033069 · Cited by 119
“, increased tumor burden, decreased chemokine, cytokine, and cellular indices of protective immunity, and increased corticosterone and VEGF levels, in HiAnx compared to LoAnx mice, and agreement with the literature regarding the effects of chronic stress on cancer [25,26], suggests that the observed results were not r…”
BackgroundResultInfluentialStress, catecholaminergic system and cancer
Križanová, O., Babula, P., & Pacák, K. (2016) · Stress · doi:10.1080/10253890.2016.1203415 · Cited by 134
“Chronic stress interferes with immune function and is thought to play a role in the etiology of tumor growth (Thaker et al., 2006).”
BackgroundLang‐Rollin, I., & Berberich, G. (2018) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2018.20.1/ilangrollin · Cited by 178
Huan, H.-B., Wen, X.-D., Chen, X., Wu, L., Wu, L., Zhang, L., Yang, D.-P., Zhang, X., Bie, P., Qian, C., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.08.016 · Cited by 131
Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent
Pantziarka, P., Bouche, G., Sukhatme, V. V., Meheus, L., Rooman, I., & Sukhatme, V. P. (2016) · ecancermedicalscience · doi:10.3332/ecancer.2016.680 · Cited by 136
“In particular beta-adrenergic activation of the cAMP-PKA signalling pathway was identified as a major mechanism by which behavioural stress enhanced tumour angiogenesis [127].”
BackgroundAn overview of cancer health disparities: new approaches and insights and why they matter
Minas, T. Z., Kiely, M., Ajao, A., & Ambs, S. (2021) · Carcinogenesis · doi:10.1093/carcin/bgaa121 · Cited by 115
“In mouse models of ovarian and breast cancer, chronic stress promotes invasive tumor growth and metastasis in a β-adrenergic signaling-dependent manner (98-100).”
BackgroundPiñero, C. P., Bruzzone, A., Sarappa, M. G., Castillo, L. F., & Lüthy, I. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01791.x · Cited by 137
“Chronic behavioural stress caused higher levels of tissue catecholamines, greater tumour burden and more invasive growth of two different b-adrenoceptor-positive ovarian cancer cell lines (HeyA8 and SKOV3ip1) intraperitoneally inoculated (Thaker et al., 2006).”
BackgroundInfluentialDhabhar, F. S., Saul, A. N., Daugherty, C., Holmes, T. H., Bouley, D. M., & Oberyszyn, T. M. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.09.004 · Cited by 117
“…shown that stress can suppress or dysregulate immune function (Glaser and Kiecolt-Glaser, 2005) and increase susceptibility to some forms of infection (Cohen et al., 1991) and cancer (Antoni et al., 2006; Ben-Eliyahu, 2003; Ben-Eliyahu et al., 2007, 1991; Saul et al., 2005; Thaker et al., 2006).”
BackgroundChang, A., Le, C. P., Walker, A. K., Creed, S. J., Pon, C. K., Albold, S., Carroll, D., Halls, M. L., Lane, J. R., Riedel, B., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.06.011 · Cited by 129
Review of yoga therapy during cancer treatment
Danhauer, S. C., Addington, E. L., Sohl, S. J., Chaoul, A., & Cohen, L. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-016-3556-9 · Cited by 114
McDonald, P. G., O’Connell, M., & Lutgendorf, S. K. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.01.003 · Cited by 130
“…in immune function among breast, cervical and ovarian patients (Andersen et al., 1998; Antoni et al., 2009; Lutgendorf et al., 2005; Nelson et al., 2008; Sephton et al., 2009; Thornton et al., 2007); however, the prognostic relevance of these associations remained uncertain (Cohen and Rabin, 1998).”
Self-citationNeurobiology of Cancer: The Role of β-Adrenergic Receptor Signaling in Various Tumor Environments
Mravec, B., Horváthová, Ľ., & Hunáková, Ľ. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217958 · Cited by 123
“However, NE is known as a potent pro-inflammatory factor and its intratumoral levels are increased under chronic stress conditions [81,82].”
BackgroundRetinopathy of prematurity: A review of pathophysiology and signaling pathways
Fevereiro‐Martins, M., Marques‐Neves, C., Guimarães, H., & Bicho, M. (2022) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2022.11.007 · Cited by 126
Dopamine Blocks Stress-Mediated Ovarian Carcinoma Growth
Moreno-Smith, M., Lu, C., Shahzad, M. M. K., Pena, G. N. A., Allen, J. K., Stone, R. L., Mangala, L. S., Han, H. D., Kim, H. S., Farley, D., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2441 · Cited by 115
“Dopamine dose–response in vivo We have previously shown that chronic stress establishes favorable conditions for promoting angiogenesis in the tumor microenvironment by SNS activation (6).”
InfluentialSelf-citationSympathetic and parasympathetic innervation in cancer: therapeutic implications
Kamiya, A., Hiyama, T. Y., Fujimura, A., & Yoshikawa, S. (2020) · Clinical Autonomic Research · doi:10.1007/s10286-020-00724-y · Cited by 126
Neeman, E., Zmora, O., & Ben‐Eliyahu, S. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1087 · Cited by 118
“facilitate tumor angiogenesis, survival, migration, proliferation, and resistance to anoikis—effects that were all blocked by b-antagonists (5, 7, 10, 11, 13, 30, 31).”
Spontaneous and Induced Animal Models for Cancer Research
Onaciu, A., Munteanu, R. A., Munteanu, V. C., Gulei, D., Ráduly, L., Feder, R., Pîrlog, R., Atanasov, A. G., Korban, S. S., Irimie, A., et al. (2020) · Diagnostics · doi:10.3390/diagnostics10090660 · Cited by 150
“Increasing evidence shows that the effects of stress on tumor angiogenesis should be taken into consideration; for example, an orthotropic mouse model of ovarian cancer exposed daily to cycles of immobilization leads to a more invasive pattern of disease [29].”
BackgroundThe Effects of Acute and Chronic Psychological Stress on Bladder Function in a Rodent Model
Smith, A. L., Leung, J., Kun, S., Zhang, R., Karagiannides, I., Raz, S., Lee, U. J., Golovatscka, V., Pothoulakis, C., Bradesi, S., et al. (2011) · Urology · doi:10.1016/j.urology.2011.06.041 · Cited by 112
The cancer-immune dialogue in the context of stress
Ma, Y., & Kroemer, G. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00949-8 · Cited by 131
“Also, these factors can reshape the tumour stroma by promoting angiogenesis, lymphogenesis, axonogenesis and extracellular matrix (ECM) formation 47,49,63–67 (Box 2).”
Influence of stress on extracellular matrix and integrin biology
Jean, C., Gravelle, P., Fournié, J., & Laurent, G. (2011) · Oncogene · doi:10.1038/onc.2011.27 · Cited by 117
“In these studies, the authors showed Oncogene that this form of stress resulted in deregulated MMP production through catecholamines synthesis in an orthothopic human ovarian carcinoma xenograft (Thaker et al., 2006).”
Lappano, R., & Maggiolini, M. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.183 · Cited by 112
Hashimoto, K., Man, S., Xu, P., Cruz‐Muñoz, W., Tang, T., Kumar, R., & Kerbel, R. S. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0960 · Cited by 113
Hu, W., Lu, C., Dong, H. H., Huang, J., Shen, D.-Y., Stone, R. L., Nick, A. M., Shahzad, M. M. K., Mora, E., Jennings, N. B., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2719 · Cited by 108
“org Cancer Res; 71(18) September 15, 2011 6033”
BackgroundInfluentialSelf-citationBlockade of β-Adrenergic Receptors Improves CD8+ T-cell Priming and Cancer Vaccine Efficacy
Daher, C., Vimeux, L., Stoeva, R., Peranzoni, E., Bismuth, G., Wieduwild, É., Lucas, B., Donnadieu, E., Bercovici, N., Trautmann, A., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0833 · Cited by 114
“Over the last decade, several studies have revealed that b-AR signaling can facilitate tumor growth and cancer progression (12, 13, 20, 35).”
BackgroundEmerging role of PKA/eNOS pathway in therapeutic angiogenesis for ischaemic tissue diseases
Bir, S. C., Xiong, Y., Kevil, C. G., & Luo, J. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs143 · Cited by 117
Heart rate variability measure in breast cancer patients and survivors: A systematic review
Arab, C., Dias, D. P. M., Barbosa, R. T. D. A., de Carvalho, T. D., Valenti, V. E., Crocetta, T. B., Ferreira, M., de Abreu, L. C., & Ferreira, C. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.02.018 · Cited by 115
Zhang, D., Ma, Q., Wang, Z., Zhang, M., Guo, K., Wang, F., & Wu, E. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-146 · Cited by 106
“Further studies suggest that both NNK and constantly high level of catecholamines modulate the activity of multiple components of the tumour microenvironment and consequently promote tumour-cell growth via badrenoceptors [4,7-9].”
BackgroundGuo, J., Bourré, L., Soden, D. M., O’Sullivan, G. C., & O’Driscoll, C. M. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.03.003 · Cited by 117
“…et al., Noninvasive imaging of lipid nanoparticle-mediated systemic delivery of small-interfering RNA to the liver, Mol Ther 18 (2010), pp. 1657-1666 Thaker et al., 2006 P.H. Thaker, L.Y. Han, A.A. Kamat, J.M. Arevalo, R. Takahashi, C. Lu, et al., Chronic stress promotes tumor growth and…”
Background
Metadata
- Authors
- Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., Jennings, N. B., Armaiz-Pena, G., Bankson, J. A., Ravoori, M., Merritt, W. M., Lin, Y. G., Mangala, L. S., Kim, T. J., Coleman, R. L., Landen, C. N., Li, Y., Felix, E., Sanguino, A. M., Newman, R. A., Lloyd, M., Gershenson, D. M., Kundra, V., Lopez-Berestein, G., Lutgendorf, S. K., Cole, S. W., & Sood, A. K.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of California, Los Angeles (US)
- University of Iowa (US)
- Corresponding author
- Sood, Anil K
- ORCID
- Venue
- Nature Medicine
- Published
- 2006-07-23
- Volume
- 12
- Issue
- 8
- Pages
- 939-944
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2151356556
- Cited by
- 1,320
- References
- 31
- Citations by year
- 2026: 69 · 2025: 83 · 2024: 100 · 2023: 88 · 2022: 71 · 2021: 82 · 2020: 90 · 2019: 66 · 2018: 64 · 2017: 55 · 2016: 70 · 2015: 74 · 2014: 59 · 2013: 72 · 2012: 63
- FWCI
- 23.64
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-11-19)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Johnson and Johnson
- National Cancer Institute (CA10929801, U01CA213759, CA-104825, CA 11079301, R01CA104825, P50CA083639)
- National Institute of Allergy and Infectious Diseases (AI 52737, R01AI052737)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Keywords
- chronic stress, ovarian carcinoma, tumor angiogenesis, tumor growth, beta2-adrenergic receptor, cAMP signaling, protein kinase A, catecholamines, vascular endothelial growth factor, matrix metalloproteinases, tumor invasion, orthotopic xenograft
- MeSH terms
- Animals, Carcinoma, Disease Models, Animal, Drug Combinations, Enzyme Inhibitors, Female, Humans, Isoproterenol, Mice, Nude, Neoplasm Transplantation, Neovascularization, Pathologic, Organ Size, Ovarian Neoplasms, Phthalazines, Pyridines, Radiography, Random Allocation, Stress, Psychological, Terbutaline, Transplantation, Heterologous, Vascular Endothelial Growth Factor A, Cell Line, Tumor, Tumor Burden, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.